Elon Musk defends Ketamine: Is the drug behind his unbalanced behaviour and what is it used for?
Elon Musk addresses recent scrutiny regarding his ketamine use, asserting it is medically supervised and aids in managing ...
Psychology Today7h
The New Amphetamine Crisis
Increasing numbers of young adults in high-stress careers are turning to amphetamines to maintain their rapid pace. But these ...
Kentucky Lantern13h
Trump, RFK Jr. worried about ‘threat’ of antidepressants. These Kentuckians push back.
Some Kentuckians who’ve taken SSRIs to treat depression are angry and confused over Trump administration rhetoric surrounding ...
The Healthy @Reader's Digest on MSN15h
New Study: This Popular Drug Sped Up Dementia Decline
A team of 12 neuroscientists in Sweden used the Swedish Dementia Registry (SveDem) to review data for over 18,700 patients ...
New Atlas20h
Initial drugs don't work for 48% of depressed people
A new study has found that antidepressant resistance is more common than was thought: 48% of people with depression have ...
Labiotech.eu1d
Depression drug trials are failing—and placebos are to blame
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
Psychology Today1d
What Are the Predominant Myths About SSRIs?
SSRIs are not addictive and cannot change your personality or make you more violent. It's important not to stigmatize psychiatric medication, as mental illness is already so stigmatized.
Science Daily2d
Nearly half of depression diagnoses could be considered treatment-resistant
Almost half of patients diagnosed with depression classify as being 'treatment-resistant' as new research suggests that many don't respond to multiple antidepressant options.
News-Medical.Net3d
Nearly half of patients with depression struggle with treatment resistance
Almost half of patients diagnosed with depression classify as being 'treatment-resistant' as new research suggests that many don't respond to multiple antidepressant options.